Recombinant Anti-(+) MDMA Neutralizing Antibody (V3S-0622-YC2) (CAT#: V3S-0622-YC2)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody is a chimeric monoclonal antibody that binds to structurally-related stimulants (i.e. (+)-methamphetamine (METH), (+)-amphetamine and (+)-MDMA), neurotransmitters (i.e.(+) - Dopamine, (-) - Norepinephrine, (-)-Epinephrine, Serotonin, γ-aminobutyric acid and L-Glutamate), selected medications ((+) - Pseudoephedrine, (+)-Norpseudoephedrine, (-)-Phenylephrine, (±)-Ephedrine, 2-Phenylethylamine and Tyramine), and other drugs of abuse ((-)-MDMA, (+)-MDA, Cocaine, Morphine and PCP). The mAb was designed to maintain the variable framework regions of the heavy and light chains of the mouse antibody including all three CDRs of both the heavy and the light chains.
Clonality Monoclonal
Host Species Human
Target Species Non-species dependence
Immunogen METH-like hapten (S)-(+)-3-(9-carboxynonyloxy)methamphetamine was covalently bound to bovine serum albumin (BSA)
Isotype IgG

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; FuncS
Application Notes The antibody is recommended for detection of (+) MDMA by ELISA, FuncS assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target (+) MDMA
Alternative Name (+) Methamphetamine; Methamphetamine; dextromethamphetamine
Research Area Neuroscience
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry